Data / Form D filings / NEXGEN FORENSIC SCIENCES, INC.
NEXGEN FORENSIC SCIENCES, INC.: Form D filings
NEXGEN FORENSIC SCIENCES, INC., a biotechnology company in Columbia, MD, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on March 24, 2023, reports $450,319 sold of a $750,000 offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10241 BRADLEY LANE, Columbia, MD, 21044
- Phone
- (443) 545-4777
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Maryland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757348
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | New notice | $750,000 | $450,319 | $299,681 | 9 | Dec 18, 2019 | sec.gov |
| Nov 6, 2018 | Amendment | $425,000 | $320,970 | $104,030 | 6 | Oct 2, 2018 | sec.gov |
| Oct 31, 2018 | New notice | $425,000 | $265,970 | $159,030 | 5 | Oct 2, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joely Gardner | Director | |
| Jeffrey Lin | Executive Officer | |
| David Weitz | Executive Officer, Director | |
| Andrew Feldman | Executive Officer, Director, Promoter | |
| Peter McKenney | Executive Officer |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Mar 20, 2023 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEXGEN FORENSIC SCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.